- Home
- XERS vs IDT Comparison
XERS vs IDT Comparison
Compare XERS & IDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XERS | IDT |
|---|---|---|
| Founded | 2005 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2018 | 1996 |
Fundamental Metrics
Financial Performance| Metric | XERS | IDT |
|---|---|---|
| Price | $7.32 | $51.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $10.43 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 196.3K |
| Earning Date | 11-06-2025 | 12-04-2025 |
| Dividend Yield | N/A | ★ 0.47% |
| EPS Growth | N/A | ★ 10.35 |
| EPS | N/A | ★ 3.22 |
| Revenue | $266,137,000.00 | ★ $1,244,681,000.00 |
| Revenue This Year | $44.37 | $0.77 |
| Revenue Next Year | $27.87 | N/A |
| P/E Ratio | ★ N/A | $15.95 |
| Revenue Growth | ★ 42.05 | 2.52 |
| 52 Week Low | $3.14 | $44.77 |
| 52 Week High | $10.08 | $71.12 |
Technical Indicators
Market Signals| Indicator | XERS | IDT |
|---|---|---|
| Relative Strength Index (RSI) | 51.89 | 53.41 |
| Support Level | $6.95 | $47.30 |
| Resistance Level | $7.26 | $54.08 |
| Average True Range (ATR) | 0.32 | 2.08 |
| MACD | 0.10 | 0.32 |
| Stochastic Oscillator | 86.67 | 62.98 |
Price Performance
Historical ComparisonAbout XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About IDT IDT Corporation Class B
IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.